Jesse K Sulzer, MD, PhD1, Ryan Pickens, MD1, Adeel Khan, MD, MPH2, David Iannitti, MD1, Dionisios Vrochides, MD, PhD1, John B Martinie, MD1. 1Atrium Health, 2Washington University
INTRODUCTION: We have previously presented methods for successful robotic duodenal surgery including sleeve resections. After demonstrating technical feasibility we sought to investigate the safety profile of this new option for conditions of the duodenum that are not amenable to endoscopic intervention and can avoid morbidity related to an open procedure.
METHODS: Retrospective review of all patients undergoing robotic duodenal sleeve resection at a tertiary care center from 2010-2018. Indications, procedural details and short and long term outcomes were reviewed
RESULTS: Nine patients unresent sleeve (segmental) resection. Median age was 50 yrs, 67% were male with a median BMI was 29.2. Sixty-seven percent were symptomatic with GI bleeding being the most common presentation. Adenoma was the most common diagnosis (56%) followed by low grade neuroendocrine tumor. Median tumor size was 35 mm and all resections achieved negative margins. Median op-time was 222 mins and EBL was 50cc. Median postop length of stay was 5 days (range 4-12 days). Four patients had complications including one bleed requiring laparoscopic reoperation, two leaks managed non-operatively and a retroperitoneal hematoma requiring drainage for persistent pain. There were two 90-day readmissions and no 90-day mortalities. Recurrent disease or strictures were not seen in any patient after a mean follow-up of 3 months (range 1-15 months).
CONCLUSION: Robotic duodenal sleeve resection is a viable alternate to open or laparoscopic duodenal resection for lesions not amenable to endoscopic intervention.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 95368
Program Number: P669
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster